Manling Wang – Trademark Portfolio

Entity Type: 01

Manling Wang holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 20 (Furniture) — 3 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CURRET and FILEMI. The owner is based in Hubei Province.

Group 2 of Zhouqiao Village,

Hengche Town, Qichun County,

Hubei Province 435300 , CN

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

UOMNN
UOMNN
Abandoned 2020
FILEMI
FILEMI
Registered 2020
CURRET
CURRET
Registered 2020
PAPIHO
PAPIHO
Abandoned 2020

Trademark Classifications

Manling Wang's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

20
Furniture (3 filings)

Furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker

30
Staple Foods (2 filings)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does Manling Wang have?

Manling Wang has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned.

What trademark classes does Manling Wang file in?

Manling Wang files trademarks across 2 Nice Classification classes. The most active classes are Class 20 (Furniture), Class 30 (Staple Foods). Class 20 covers furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker.

What are Manling Wang's most well-known trademarks?

Manling Wang's registered trademark portfolio includes well-known marks such as CURRET and FILEMI. These are among 2 currently registered trademarks in the portfolio.

What is Manling Wang's trademark registration success rate?

Manling Wang has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.